The expression of dual‐specificity phosphatase 1 mRNA is downregulated in lesional psoriatic skin

No abstract is available for this paper.

• Publication year

  2013

• Venue

  British Journal of Dermatology

• Publication date

  2013-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1111/bjd.12020PMID 22924482
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Attenuation of the acute inflammatory response by dual specificity phosphatase 1 by inhibition of p38 MAP kinase.

  2011cited by this paper
• Transcriptional Regulation of Human Dual Specificity Protein Phosphatase 1 (DUSP1) Gene by Glucocorticoids

  2010cited by this paper
• Cross-talk between the p38α and JNK MAPK Pathways Mediated by MAP Kinase Phosphatase-1 Determines Cellular Sensitivity to UV Radiation*

  2010cited by this paper
• Adalimumab therapy rapidly inhibits p38 mitogen‐activated protein kinase activity in lesional psoriatic skin preceding clinical improvement

  2010cited by this paper
• Preferential inhibition of the mRNA expression of p38 mitogen‐activated protein kinase regulated cytokines in psoriatic skin by anti‐TNFα therapy

  2010cited by this paper
• Akt2 Modulates Glucose Availability and Downstream Apoptotic Pathways during Development*

  2010cited by this paper
• Glucocorticoids Enhance Toll-Like Receptor 2 Expression in Human Keratinocytes Stimulated with Propionibacterium acnes or Proinflammatory Cytokines

  2010cited by this paper
• Glucocorticoids enhance Toll-like receptor 2 expression in human keratinocytes stimulated with Propionibacterium acnes or proinflammatory cytokines.

  2009cited by this paper
• The expression and phosphorylation of eukaryotic initiation factor 4E are increased in lesional psoriatic skin

  2009cited by this paper
• Modulation of immediate early gene expression by tristetraprolin in the differentiation of 3T3-L1 cells.

  2008cited by this paper
• Pro‐inflammatory cytokine release in keratinocytes is mediated through the MAPK signal‐integrating kinases

  2008cited by this paper
• The kinases MSK1 and MSK2 act as negative regulators of Toll-like receptor signaling

  2008cited by this paper
• MKP-1 mRNA Stabilization and Translational Control by RNA-Binding Proteins HuR and NF90

  2008cited by this paper
• Retinoic Acid Utilizes CREB and USF1 in a Transcriptional Feed-Forward Loop in Order To Stimulate MKP1 Expression in Human Immunodeficiency Virus-Infected Podocytes

  2008cited by this paper
• Protecting the stress response, guarding the MKP-1 mRNA

  2008cited by this paper
• The kinase p38α serves cell type–specific inflammatory functions in skin injury and coordinates pro- and anti-inflammatory gene expression

  2008cited by this paper
• Mitogen-Activated Protein (MAP) Kinase/MAP Kinase Phosphatase Regulation: Roles in Cell Growth, Death, and Cancer

  2008cited by this paper
• Dexamethasone suppresses interleukin-1beta-induced human beta-defensin 2 mRNA expression: involvement of p38 MAPK, JNK, MKP-1, and NF-kappaB transcriptional factor in A549 cells.

  2007cited by this paper
• Current and future management of psoriasis.

  2007cited by this paper
• Modulation of mRNA stability as a novel therapeutic approach.

  2007cited by this paper
• Targeting dual-specificity phosphatases: manipulating MAP kinase signalling and immune responses

  2007cited by this paper
• MAPK phosphatases — regulating the immune response

  2007cited by this paper
• Expression and localization of the activated mitogen-activated protein kinase in lesional psoriatic skin.

  2007cited by this paper
• Dimethylfumarate specifically inhibits the mitogen and stress-activated kinases 1 and 2 (MSK1/2): possible role for its anti-psoriatic effect.

  2007cited by this paper
• Mitogen- and stress-activated protein kinase 2 and cyclic AMP response element binding protein are activated in lesional psoriatic epidermis.

  2007cited by this paper
• Dexamethasone suppresses interleukin-1β-induced human β-defensin 2 mRNA expression: involvement of p38 MAPK, JNK, MKP-1, and NF-κB transcriptional factor in A549 cells

  2007cited by this paper
• Essential Role of MAPK Phosphatase-1 in the Negative Control of Innate Immune Responses

  2006cited by this paper
• Mitogen- and stress-activated protein kinase 1 is activated in lesional psoriatic epidermis and regulates the expression of pro-inflammatory cytokines.

  2006cited by this paper
• Protein Expression of TNF-α in Psoriatic Skin Is Regulated at a Posttranscriptional Level by MAPK-Activated Protein Kinase 21

  2006cited by this paper
• DUSP Meet Immunology: Dual Specificity MAPK Phosphatases in Control of the Inflammatory Response1

  2006cited by this paper
• AU-rich elements and associated factors: are there unifying principles?

  2006cited by this paper
• Dual-specificity phosphatase 1: a critical regulator of innate immune responses.

  2006cited by this paper
• The mitogen‐activated protein kinases p38 and ERK1/2 are increased in lesional psoriatic skin

  2005cited by this paper
• Expression of mitogen-activated protein kinase phosphatase 1, a negative regulator of the mitogen-activated protein kinases, in rheumatoid arthritis: up-regulation by interleukin-1beta and glucocorticoids.

  2004cited by this paper
• Mitogen- and Stress-Activated Protein Kinase 1 Mediates cAMP Response Element-Binding Protein Phosphorylation and Activation by Neurotrophins

  2004cited by this paper
• Extracellular regulated kinase and c-Jun N-terminal kinase are activated in psoriatic involved epidermis.

  2002cited by this paper
• Dexamethasone Causes Sustained Expression of Mitogen-Activated Protein Kinase (MAPK) Phosphatase 1 and Phosphatase-Mediated Inhibition of MAPK p38

  2002cited by this paper
• Transcriptional Induction of Mitogen-activated Protein Kinase Phosphatase 1 by Retinoids

  2002cited by this paper
• Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation.

  2001cited by this paper
• Specificity and mechanism of action of some commonly used protein kinase inhibitors.

  2000cited by this paper
• Correlation between Sustained c-Jun N-terminal Protein Kinase Activation and Apoptosis Induced by Tumor Necrosis Factor-α in Rat Mesangial Cells*

  1998cited by this paper
• Inhibition of the Expression of Mitogen-activated Protein Phosphatase-1 Potentiates Apoptosis Induced by Tumor Necrosis Factor-α in Rat Mesangial Cells*

  1998cited by this paper
• Disruption of the erp/mkp-1 gene does not affect mouse development: normal MAP kinase activity in ERP/MKP-1-deficient fibroblasts.

  1996cited by this paper
• Oxidative stress and heat shock induce a human gene encoding a protein-tyrosine phosphatase

  1992cited by this paper

• Loss-of-function variants in DUSP1 encoding dual specificity phosphatase 1 cause palmoplantar keratoderma.

  2025cites this paper
• Single-cell sequencing-based study of ferroptosis mechanisms in heat stroke: identification of key biomarkers and dynamic analysis of the immune microenvironment

  2025cites this paper
• Topical delivery of pterostilbene nanoemulgel ameliorates imiquimod-induced psoriasis-like skin inflammation in mice.

  2025cites this paper
• p38α deficiency ameliorates psoriasis development by downregulating STAT3-mediated keratinocyte proliferation and cytokine production

  2024cites this paper
• Unraveling the Genetics of Shared Clinical and Serological Manifestations in Patients With Systemic Inflammatory Autoimmune Diseases

  2024cites this paper
• The E3 Ubiquitin Protein Ligase LINCR Amplifies the TLR-Mediated Signals through Direct Degradation of MKP1

  2024cites this paper
• Expression profile of mRNAs and miRNAs related to mitogen-activated kinases in HaCaT cell culture treated with lipopolysaccharide a and adalimumab

  2024influential citation
• Gene expression profile of mitogen-activated kinases and microRNAs controlling their expression in HaCaT cell culture treated with lipopolysaccharide A and cyclosporine A

  2024cites this paper
• Methylprednisolone Promotes Mycobacterium smegmatis Survival in Macrophages through NF-κB/DUSP1 Pathway

  2023cites this paper
• The mRNA Expression Profile of Psoriatic Lesion Distinct from Non-Lesion

  2022cites this paper
• New insights into the novel anti-inflammatory mode of action of glucocorticoids

  2020cites this paper
• Glucocorticoid receptor α and MKP-1 as candidate biomarkers for treatment response and disease activity in Vogt-Koyanagi-Harada disease.

  2019cites this paper
• DUSP1/MKP‐1 regulates proliferation and apoptosis in keratinocytes through the ERK/Elk‐1/Egr‐1 signaling pathway

  2019cites this paper
• Role of Dual-Specificity Phosphatase 1 in Glucocorticoid-Driven Anti-inflammatory Responses

  2019cites this paper
• Biomechanical Factors in Psoriatic Disease: Defective Repair Exertion as a Potential Cause. Hypothesis Presentation and Literature Review

  2019cites this paper
• MAPK Phosphatase-1 Deficiency Exacerbates the Severity of Imiquimod-Induced Psoriasiform Skin Disease

  2018cites this paper
• Pharmacological evaluation of combination of plant steroids and low dose Glucocorticoid for treatment of inflammatory disorders in experimental animals

  2017cites this paper
• Genome-Wide DNA Methylation Profiling Identifies Differential Methylation in Uninvolved Psoriatic Epidermis.

  2017cites this paper
• Crosstalk between Signaling Pathways in Pemphigus: A Role for Endoplasmic Reticulum Stress in p38 Mitogen-Activated Protein Kinase Activation?

  2017cites this paper
• Dual specificity protein phosphatase 1 ( DUSP 1 ) in normal pregnancy and preeclampsia

  2016cites this paper
• Mitogen-activated Protein Kinase Phosphatases in Inflammation and as Anti-inflammatory Drug Targets

  2014cites this paper
• Mitogen-activated protein kinase phosphatase 1 as an inflammatory factor and drug target.

  2014cites this paper
• The Role of p38 MAPK in the Aetiopathogenesis of Psoriasis and Psoriatic Arthritis

  2013cites this paper
• p38 MAPK Signaling in Pemphigus: Implications for Skin Autoimmunity

  2013cites this paper
• Autoimmunity Diseases of the Skin

  2013cites this paper